Perspective Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for CATX

Based on 1 analyst offering 12 month price targets for Perspective Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell CATX stock?

Based on 1 analyst offering ratings for Perspective Therapeutics Inc.
Strong Buy
0 analysts 0%
1 analysts 100%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CATX stock forecasts and price targets.

CATX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Bottom 13%

1 of 1

CATX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
RBOT$0.61$9.00+1,365.80%Strong Buy
XAIR$2.50$12.25+390.00%Strong Buy
ASXC$0.29$1.50+426.32%Strong Buy

Perspective Therapeutics Stock Forecast FAQ

Is Perspective Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: CATX) stock is to Buy CATX stock.

Out of 1 analyst, 0 (0%) are recommending CATX as a Strong Buy, 1 (100%) are recommending CATX as a Buy, 0 (0%) are recommending CATX as a Hold, 0 (0%) are recommending CATX as a Sell, and 0 (0%) are recommending CATX as a Strong Sell.

If you're new to stock investing, here's how to buy Perspective Therapeutics stock.

What is CATX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CATX price target, the average CATX price target is $1.20, with the highest CATX stock price forecast at $1.20 and the lowest CATX stock price forecast at $1.20.

The Wall Street analyst predicted that Perspective Therapeutics's share price could reach $1.20 by May 19, 2024. The average Perspective Therapeutics stock price prediction forecasts a potential upside of 328.57% from the current CATX share price of $0.28.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.